"Relationship between insight into cognition, extrapyramidal symptoms and mental illness in schizophrenia." Australian and New Zealand Journal of Psychiatry, 45(7), pp. 596–597
Acknowledgements
This trial was financed via an academic partnership between the Louis-H Lafontaine Foundation and AstraZeneca Pharmaceuticals and via a grant from the Fonds de la Recherche en Santé du Québec (FRSQ). E.S. is holder of the Eli Lilly Canada Chair of Schizophrenia from the University of Montreal. S.P. is holder of a research scholarship from the FRSQ.